Call it a sad commentary on the state of the medical imaging market: Fidelity Medical hasexited the industry in favor of greener pastures in retail stationery.The Florham Park, NJ, company this month announced that it hassold its x-ray digitization
Call it a sad commentary on the state of the medical imaging market: Fidelity Medical hasexited the industry in favor of greener pastures in retail stationery.The Florham Park, NJ, company this month announced that it hassold its x-ray digitization business to Chester Holdings Ltd.in a transaction valued at $900,000.
Fidelity has had a rough time in the industry since 1992, whenthen-CEO Efraim Landa left the firm after revealing that the company'sbalance sheet had been inflated (SCAN 8/26/92).
Fidelity hired former Siemens executive Werner Haas in an effortto turn the company around. Red ink continued to flow from thefirm, however, and a shareholder lawsuit related to the bogusfinancial results dogged the company. Fidelity posted a net lossof $5 million in 1992, a net loss of $10.1 million in 1993 anda net loss of $1.9 million last year. Fidelity postponed the filingof its 1994 results for several months due to doubts about thecompany's future (SCAN 3/1/95 and 2/1/95).
Fidelity began divesting its businesses in 1993, when it soldan unprofitable Israeli subsidiary. It shifted its focus awayfrom medical imaging when it bought U.K. stationery retailer CornicheDistribution last month (SCAN 4/12/95).
Fidelity completed its exit from radiology this month whenit sold all of its stock in medical imaging products in exchangefor 2.2 million shares of Fidelity common stock acquired by Chesterin connection with the Corniche acquisition. Fidelity also receiveda 180-day promissory note for $200,000.
Fidelity's new chairman, Brian Baylis, said the company madethe move to exit a business where it had been generating yearsof losses.
"Fidelity's board of directors believes that Fidelity'sfuture lies outside (medical imaging)," Baylis said. "Thedisposition of the medical imaging products business will allowFidelity to focus its attention and resources on the developmentand expansion of its stationery operations."
Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS
February 17th 2025In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.